ATE473235T1 - Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung - Google Patents
Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendungInfo
- Publication number
- ATE473235T1 ATE473235T1 AT03703396T AT03703396T ATE473235T1 AT E473235 T1 ATE473235 T1 AT E473235T1 AT 03703396 T AT03703396 T AT 03703396T AT 03703396 T AT03703396 T AT 03703396T AT E473235 T1 ATE473235 T1 AT E473235T1
- Authority
- AT
- Austria
- Prior art keywords
- btm
- sim
- motif
- therapy
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020003184A KR20030062789A (ko) | 2002-01-19 | 2002-01-19 | 생체분자 전달 펩타이드 ｓｉｍ2-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| PCT/KR2003/000121 WO2003059940A1 (en) | 2002-01-19 | 2003-01-20 | Biomolecule transduction motif sim-2-btm and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473235T1 true ATE473235T1 (de) | 2010-07-15 |
Family
ID=19718641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03703396T ATE473235T1 (de) | 2002-01-19 | 2003-01-20 | Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7354737B2 (de) |
| EP (1) | EP1468011B1 (de) |
| JP (1) | JP4361370B2 (de) |
| KR (2) | KR20030062789A (de) |
| AT (1) | ATE473235T1 (de) |
| AU (1) | AU2003206161A1 (de) |
| DE (1) | DE60333254D1 (de) |
| WO (1) | WO2003059940A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030062788A (ko) | 2002-01-19 | 2003-07-28 | 포휴먼텍(주) | 생체분자 전달 펩타이드 ｍｐｈ1-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| KR100591936B1 (ko) * | 2002-11-12 | 2006-06-22 | 포휴먼텍(주) | 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용 |
| KR100897915B1 (ko) | 2004-11-03 | 2009-05-18 | 포휴먼텍(주) | 경피전달을 위한 약제 조성물 |
| JP2010509181A (ja) | 2005-11-04 | 2010-03-25 | フォーヒューマンテック・カンパニー・リミテッド | 融合ポリペプチドを細胞へ輸送する方法 |
| CA2638915A1 (en) * | 2006-02-10 | 2007-08-23 | The Regents Of The University Of California | Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| CN101490080A (zh) | 2006-07-24 | 2009-07-22 | 为人技术株式会社 | 用于缓解和治疗缺血性病症的药物组合物及其输送方法 |
| JP2010537632A (ja) * | 2007-08-29 | 2010-12-09 | タフツ ユニバーシティー | 組織及び細胞への核酸、タンパク質、薬物、及びアデノウイルスの送達を向上させるための細胞透過性ペプチドの製造及び使用方法、組成物並びにキット |
| US7981446B2 (en) | 2007-11-26 | 2011-07-19 | Forhumantech. Co., Ltd. | Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| EP2591093B1 (de) | 2010-07-07 | 2018-11-28 | FUJIFILM Cellular Dynamics, Inc. | Endothelzellenproduktion durch programmierung |
| EP2673358B1 (de) | 2011-02-08 | 2019-01-09 | FUJIFILM Cellular Dynamics, Inc. | Herstellung blutbildender vorläuferzellen durch programmierung |
| SG11201407635XA (en) | 2012-05-30 | 2014-12-30 | Univ Cornell | Generation of functional and durable endothelial cells from human amniotic fluid-derived cells |
| IN2015DN01765A (de) | 2012-08-20 | 2015-05-29 | Univ California |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| AU2001233114A1 (en) * | 2000-02-04 | 2001-08-14 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| JP2004505637A (ja) * | 2000-08-04 | 2004-02-26 | フロリダ アトランティック ユニヴァーシティ | ガン関連ｓｉｍ２遺伝子 |
| KR100591936B1 (ko) * | 2002-11-12 | 2006-06-22 | 포휴먼텍(주) | 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용 |
-
2002
- 2002-01-19 KR KR1020020003184A patent/KR20030062789A/ko unknown
-
2003
- 2003-01-20 EP EP03703396A patent/EP1468011B1/de not_active Expired - Lifetime
- 2003-01-20 KR KR1020047011205A patent/KR100978344B1/ko active IP Right Grant
- 2003-01-20 US US10/501,964 patent/US7354737B2/en not_active Expired - Fee Related
- 2003-01-20 DE DE60333254T patent/DE60333254D1/de not_active Expired - Lifetime
- 2003-01-20 AT AT03703396T patent/ATE473235T1/de not_active IP Right Cessation
- 2003-01-20 JP JP2003560042A patent/JP4361370B2/ja not_active Expired - Fee Related
- 2003-01-20 AU AU2003206161A patent/AU2003206161A1/en not_active Abandoned
- 2003-01-20 WO PCT/KR2003/000121 patent/WO2003059940A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| DE60333254D1 (de) | 2010-08-19 |
| KR20040085154A (ko) | 2004-10-07 |
| US7354737B2 (en) | 2008-04-08 |
| WO2003059940A1 (en) | 2003-07-24 |
| JP4361370B2 (ja) | 2009-11-11 |
| JP2005532037A (ja) | 2005-10-27 |
| AU2003206161A1 (en) | 2003-07-30 |
| KR20030062789A (ko) | 2003-07-28 |
| EP1468011A1 (de) | 2004-10-20 |
| KR100978344B1 (ko) | 2010-08-26 |
| US20050222386A1 (en) | 2005-10-06 |
| EP1468011A4 (de) | 2005-10-12 |
| EP1468011B1 (de) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE471336T1 (de) | Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung | |
| Akgul et al. | In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins | |
| JP2022036938A (ja) | ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド | |
| ATE473235T1 (de) | Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung | |
| MX357691B (es) | Il-15 y il-15r-alfa mejoradas para expresion en celulas mamiferas. | |
| EP4174179A3 (de) | Rna-haltige modifizierte nukleoside und verfahren zur verwendung davon | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| ATE550356T1 (de) | Chimäre t-zellen-rezeptoren sowie entsprechende materialien und verwendungsverfahren | |
| Kristensen et al. | Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation | |
| Lengler et al. | Antagonistic action of Six3 and Prox1 at the γ-crystallin promoter | |
| MX9206376A (es) | Liberacion de proteinas por terapia genica | |
| Mulero et al. | Protein cofactors are essential for high-affinity DNA binding by the nuclear factor κB RelA subunit | |
| DK1807518T3 (da) | Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf | |
| Borel et al. | Biogenesis of polytopic membrane proteins: membrane segments of P-glycoprotein sequentially translocate to span the ER membrane | |
| Eid et al. | Total chemical synthesis of ISGylated-ubiquitin hybrid chain assisted by acetamidomethyl derivatives with dual functions | |
| EP1277843A3 (de) | Neue humane Gene und Genexpressionsprodukte die in Zusammenhang mit Darmkrebs stehen | |
| Xiong et al. | Identification of a functional nuclear localization signal within the human USP22 protein | |
| Oh et al. | Eukaryotic translation initiation factor-6 enhances histamine and IL-2 production in mast cells | |
| Remelia et al. | The use of cell-penetrating peptide for delivery of recombinant transcription factor DNA into primary human fibroblast | |
| Bartz et al. | Reconstitution of vesicular transport to Rab11-positive recycling endosomes in vitro | |
| Yasuda et al. | Aggregation of yeast cells induced by the Arg-Gly-Asp motif-containing fragment of high-molecular-mass cell-adhesion protein MFBA, derived from the basidiomycetous mushroom Lentinus edodes | |
| JP2003505043A (ja) | 血清アルブミンのキメラポリペプチド及びそれらに関する利用 | |
| Wang et al. | Understanding the energetics of translation in bacterial and eukaryotic ribosomes | |
| Yan et al. | Detection of membrane protein interactions by cell-based tango assays | |
| DE60310708D1 (de) | In vivo stabilsierung von plasmiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |